OPNT
Opiant Pharmaceuticals, Inc. [OPNT] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
OPNT Stock Summary
In the News
OPNT Financial details
Company Rating
-
Market Cap
108.8M
Income
-33.49M
Revenue
191.43M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
37
Optionable
No
Shortable
Yes
Earnings
03 Aug 2022
P/E
-3.1
Forward P/E
-
PEG
-0.02
P/S
0.61
P/B
5.18
P/C
-
P/FCF
-6.08
Quick Ratio
5.03
Current Ratio
5.48
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-6.58
EPS next Y
-
EPS next Q
-
EPS this Y
-254.55%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-26.95%
Revenue last 5Y
17.16%
Revenue Q/Q
7374.3%
EPS Q/Q
-16.45%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-82%
ROE
-115%
ROC
-0.94%
Gross Margin
99%
Oper. Margin
-18%
Profit Margin
-19%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
7.34-27.36
52W High
-
52W Low
-
RSI
-
Rel Volume
7.78
Avg Volume
72.36K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.831589
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
Company Profile
- Volume Average 72.36K
- Market Capitalization 108.8M
- Employee 37
- CEO Dr. Roger Crystal M.D.
- Headquarters Santa Monica,CA,US
- IPO Date 2007-06-04
-
Website
https://www.opiant.com 
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.
